Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice

Journal of Lipid Research

Volumn 54, Issue 3, 2013, Pages 806-815

  Chao, Lily C ^a   Soto, Erin ^b   Hong, Cynthia ^a   Ito, Ayaka ^a   Pei, Liming ^b   Chawla, Ajay ^c   Conneely, Orla M ^d   Tangirala, Rajendra K ^a   Evans, Ronald M ^a,b   Tontonoz, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Ly6C; Nuclear receptor; Nur77

Indexed keywords

INTERLEUKIN 4; LIPOPOLYSACCHARIDE; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; NUCLEAR RECEPTOR NUR77; STAT6 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CHOLESTEROL DIET; CONTROLLED STUDY; FLOW CYTOMETRY; GENE INDUCTION; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ATHEROSCLEROSIS; FLOW CYTOMETRY; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84874062213     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M034157     Document Type: Article

References (41)

1. Tontonoz, P. 2011. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors. Cold Spring Harb. Symp. Quant. Biol. 76 : 129-137.
2. Li, A. C., C. J. Binder, A. Gutierrez, K. K. Brown, C. R. Plotkin, J. W. Pattison, A. F. Valledor, R. A. Davis, T. M. Willson, J. L. Witztum, et al. 2004. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J. Clin. Invest. 114 : 1564-1576.
3. Hamers, A. A., M. Vos, F. Rassam, G. Marinkovi?, K. Kurakula, P. J. van Gorp, M. P. de Winther, M. J. Gijbels, V. de Waard, and C. J. de Vries. 2012. Bone marrow-specifi c defi ciency of nuclear receptor Nur77 enhances atherosclerosis. Circ. Res. 110 : 428-438.
4. Hanna, R. N., I. Shaked, H. G. Hubbeling, J. A. Punt, R. Wu, E. Herrley, C. Zaugg, H. Pei, F. Geissmann, K. Ley, et al. 2012. NR4A1 (Nur77) deletion polarizes macrophages toward an infl ammatory phenotype and increases atherosclerosis. Circ. Res. 110 : 416-427.
5. Zhao, Y., D. A. Howatt, F. Gizard, T. Nomiyama, H. M. Findeisen, E. B. Heywood, K. L. Jones, O. M. Conneely, A. Daugherty, and D. Bruemmer. 2010. Defi ciency of the NR4A orphan nuclear receptor NOR1 decreases monocyte adhesion and atherosclerosis. Circ. Res. 107 : 501-511.
6. Maxwell, M. A., and G. E. Muscat. 2006. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl. Recept. Signal. 4 : e002.
7. Chao, L. C., K. Wroblewski, Z. Zhang, L. Pei, L. Vergnes, O. R. Ilkayeva, S. Y. Ding, K. Reue, M. J. Watt, C. B. Newgard, et al. 2009. Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes. 58 : 2788-2796.
8. Chao, L. C., Z. Zhang, L. Pei, T. Saito, P. Tontonoz, and P. F. Pilch. 2007. Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol. Endocrinol. 21 : 2152-2163.
9. Cheng, L. E., F. K. Chan, D. Cado, and A. Winoto. 1997. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 16 : 1865-1875.
10. Pei, L., H. Waki, B. Vaitheesvaran, D. C. Wilpitz, I. J. Kurland, and P. Tontonoz. 2006. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat. Med. 12 : 1048-1055.
11. Woronicz, J. D., B. Calnan, V. Ngo, and A. Winoto. 1994. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature. 367 : 277-281.
12. Zetterström, R. H., L. Solomin, L. Jansson, B. J. Hoffer, L. Olson, and T. Perlmann. 1997. Dopamine neuron agenesis in Nurr1-defi cient mice. Science. 276 : 248-250.
13. Mullican, S. E., S. Zhang, M. Konopleva, V. Ruvolo, M. Andreeff, J. Milbrandt, and O. M. Conneely. 2007. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat. Med. 13 : 730-735.
14. Ramirez-Herrick, A. M., S. E. Mullican, A. M. Sheehan, and O. M. Conneely. 2011. Reduced NR4A gene dosage leads to mixed myelodysplastic/ myeloproliferative neoplasms in mice. Blood. 117 : 2681-2690.
15. Pei, L., A. Castrillo, M. Chen, A. Hoffmann, and P. Tontonoz. 2005. Induction of NR4A orphan nuclear receptor expression in macrophages in response to infl ammatory stimuli. J. Biol. Chem. 280 : 29256-29262.
16. Pei, L., A. Castrillo, and P. Tontonoz. 2006. Regulation of macrophage infl ammatory gene expression by the orphan nuclear receptor Nur77. Mol. Endocrinol. 20 : 786-794.
17. Nomiyama, T., Y. Zhao, F. Gizard, H. M. Findeisen, E. B. Heywood, K. L. Jones, O. M. Conneely, and D. Bruemmer. 2009. Defi ciency of the NR4A neuron-derived orphan receptor-1 attenuates neointima formation after vascular injury. Circulation. 119 : 577-586.
18. Bonta, P. I., C. M. van Tiel, M. Vos, T. W. Pols, J. V. van Thienen, V. Ferreira, E. K. Arkenbout, J. Seppen, C. A. Spek, T. van der Poll, et al. 2006. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and infl ammatory responses. Arterioscler. Thromb. Vasc. Biol. 26 : 2288-2294.
19. Waki, H., K. W. Park, N. Mitro, L. Pei, R. Damoiseaux, D. C. Wilpitz, K. Reue, E. Saez, and P. Tontonoz. 2007. The small molecule harmine is an antidiabetic cell-type-specifi c regulator of PPARgamma expression. Cell Metab. 5 : 357-370.
20. Lee, S. L., R. L. Wesselschmidt, G. P. Linette, O. Kanagawa, J. H. Russell, and J. Milbrandt. 1995. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science. 269 : 532-535.
21. Ponnio, T., Q. Burton, F. A. Pereira, D. K. Wu, and O. M. Conneely. 2002. The nuclear receptor Nor-1 is essential for proliferation of the semicircular canals of the mouse inner ear. Mol. Cell. Biol. 22 : 935-945.
22. Hong, C., M. N. Bradley, X. Rong, X. Wang, A. Wagner, V. Grijalva, L. W. Castellani, J. Salazar, S. Realegeno, R. Boyadjian, et al. 2012. LXRalpha is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-defi cient mice. J. Lipid Res. 53 : 1126-1133.
23. Tangirala, R. K., E. M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-defi cient and apolipoprotein E-defi cient mice. J. Lipid Res. 36 : 2320-2328.
24. Bradley, M. N., C. Hong, M. Chen, S. B. Joseph, D. C. Wilpitz, X. Wang, A. J. Lusis, A. Collins, W. A. Hseuh, J. L. Collins, et al. 2007. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J. Clin. Invest. 117 : 2337-2346.
25. Tangirala, R. K., E. D. Bischoff, S. B. Joseph, B. L. Wagner, R. Walczak, B. A. Laffi tte, C. L. Daige, D. Thomas, R. A. Heyman, D. J. Mangelsdorf, et al. 2002. Identifi cation of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. USA. 99 : 11896-11901.
26. Joseph, S. B., A. Castrillo, B. A. Laffi tte, D. J. Mangelsdorf, and P. Tontonoz. 2003. Reciprocal regulation of infl ammation and lipid metabolism by liver X receptors. Nat. Med. 9 : 213-219.
27. Odegaard, J. I., and A. Chawla. 2011. Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6 : 275-297.
28. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3 : 23-35.
29. Shirey, K. A., L. E. Cole, A. D. Keegan, and S. N. Vogel. 2008. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J. Immunol. 181 : 4159-4167.
30. Szanto, A., B. L. Balint, Z. S. Nagy, E. Barta, B. Dezso, A. Pap, L. Szeles, S. Poliska, M. Oros, R. M. Evans, et al. 2010. STAT6 transcription factor is a facilitator of the nuclear receptor PPARgammaregulated gene expression in macrophages and dendritic cells. Immunity. 33 : 699-712.
31. Weng, M., D. Huntley, I. F. Huang, O. Foye-Jackson, L. Wang, A. Sarkissian, Q. Zhou, W. A. Walker, B. J. Cherayil, and H. N. Shi. 2007. Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis. J. Immunol. 179 : 4721-4731.
32. Hanna, R. N., L. M. Carlin, H. G. Hubbeling, D. Nackiewicz, A. M. Green, J. A. Punt, F. Geissmann, and C. C. Hedrick. 2011. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat. Immunol. 12 : 778-785.
33. McMorrow, J. P., and E. P. Murphy. 2011. Infl ammation: a role for NR4A orphan nuclear receptors? Biochem. Soc. Trans. 39 : 688-693.
34. Mix, K. S., K. McMahon, J. P. McMorrow, D. E. Walkenhorst, A. M. Smyth, B. L. Petrella, M. Gogarty, U. Fearon, D. Veale, M. G. Attur, et al. 2012. Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription. Arthritis Rheum. 64 : 2126-2136.
35. Mix, K. S., M. G. Attur, H. Al-Mussawir, S. B. Abramson, C. E. Brinckerhoff, and E. P. Murphy. 2007. Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage. J. Biol. Chem. 282 : 9492-9504.
36. Saijo, K., B. Winner, C. T. Carson, J. G. Collier, L. Boyer, M. G. Rosenfeld, F. H. Gage, and C. K. Glass. 2009. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from infl ammation-induced death. Cell. 137 : 47-59.
37. Caesar, R., F. Fak, and F. Backhed. 2010. Effects of gut microbiota on obesity and atherosclerosis via modulation of infl ammation and lipid metabolism. J. Intern. Med. 268 : 320-328.
38. Mencarelli, A., S. Cipriani, B. Renga, A. Bruno, C. D'Amore, E. Distrutti, and S. Fiorucci. 2012. VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal infl ammation. PLoS ONE. 7 : e45425.
39. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19 : 71-82.
40. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science. 327 : 656-661.
41. Gautier, E. L., A. Chow, R. Spanbroek, G. Marcelin, M. Greter, C. Jakubzick, M. Bogunovic, M. Leboeuf, N. van Rooijen, A. J. Habenicht, et al. 2012. Systemic analysis of PPARgamma in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of infl ammation and airway immunity. J. Immunol. 189 : 2614-2624.